Treatment of Lymph Node and Spleen Sarcoidosis: Structured Evidence-Based Regimen
Sarcoidosis involving the lymph nodes and spleen is a systemic presentation that requires a structured pharmacological approach. The regimen for this form of the disease is informed by clinical evidence specific to this organ involvement.
Treatment approach
The protocol for this presentation centres on a targeted biologic therapy — an anti-TNF agent — as the primary pharmacological intervention. Full agent selection, administration details, and monitoring parameters are available in the complete structured protocol.
References
- Small, short-term studies have shown infliximab to be effective in reducing sarcoidosis symptoms in patients who did not respond to other treatments.
- Anecdotal reports have shown adalimumab to be effective in reducing sarcoidosis symptoms.
View source ↗